US 9150591
Heterocyclic compound and use thereof
granted A61PA61P25/00A61P25/14
Quick answer
US patent 9150591 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/18, A61P25/20